Hypothermic oxygenated perfusion versus standard treatment of donor hearts in heart transplantation: extended follow-up of the NIHP2019 trial
Filip Rega, Guillaume Lebreton, Marylou Para, Sebastian Michel, René Schramm, Emmanuelle Begot, Katrien Vandendriessche, Christine Kamla, Gino Gerosa, Marius Berman, Udo Boeken, Stephen Clark, Aaron Ranasinghe, Fabio Ius, Alberto Forteza, Aldina Pivodic, Felix Hennig, Sabina Guenther, Pradeep Kaul, Adelheid Goerler, Arezu Aliabadi-Zuckermann, Jan F Gummert, Johan Van Cleemput, Andreas Zuckermann, Christoph Knosalla, Göran Dellgren, Andreas Wallinder · 2026
Read Hypothermic oxygenated perfusion versus standard treatment of donor hearts in heart transplantation: extended follow-up of the NIHP2019 trial by Filip Rega, Guillaume Lebreton, Marylou Para, Sebastian Michel, René Schramm, Emmanuelle Begot, Katrien Vandendriessche, Christine Kamla, Gino Gerosa, Marius Berman, Udo Boeken, Stephen Clark, Aaron Ranasinghe, Fabio Ius, Alberto Forteza, Aldina Pivodic, Felix Hennig, Sabina Guenther, Pradeep Kaul, Adelheid Goerler, Arezu Aliabadi-Zuckermann, Jan F Gummert, Johan Van Cleemput, Andreas Zuckermann, Christoph Knosalla, Göran Dellgren, Andreas Wallinder (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13500156.txt.
Description
Rega and colleagues reported extended twelve-month results in 2026 from the NIHP2019 trial, the first randomized test of hypothermic oxygenated perfusion, a cold, oxygen-fed machine preservation method, for donor hearts. Static cold storage, the standard, lets oxygen starvation injure the organ. Across fifteen centers in eight European countries, about two hundred transplant recipients received hearts preserved by machine or by cold storage; early results already favored the machine at thirty days.
At twelve months the combined outcome of death, graft problems, rejection, and severe early graft failure struck about a third of machine-preserved patients against nearly half of cold-storage patients. Severe early graft dysfunction showed the widest gap, at about one in twenty against one in five, and deaths also ran lower with the machine, though less decisively. Adjusted analysis agreed. The authors conclude the early gains persisted to one year without new safety worries.
Catalog record
| CREATOR | Filip Rega, Guillaume Lebreton, Marylou Para, Sebastian Michel, René Schramm, Emmanuelle Begot, Katrien Vandendriessche, Christine Kamla, Gino Gerosa, Marius Berman, Udo Boeken, Stephen Clark, Aaron Ranasinghe, Fabio Ius, Alberto Forteza, Aldina Pivodic, Felix Hennig, Sabina Guenther, Pradeep Kaul, Adelheid Goerler, Arezu Aliabadi-Zuckermann, Jan F Gummert, Johan Van Cleemput, Andreas Zuckermann, Christoph Knosalla, Göran Dellgren, Andreas Wallinder |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |